8^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain

OMICS International is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. After a successful conference of Pharmaceutica 2015, OMICS International is currently bringing forth "8^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems"  (Pharmaceutica 2016) slated on March 07-09, 2016 at Madrid, Spain.

Pharmaceutica 2016 covers various aspects of Pre-formulation Considerations, Formulation Aspects for Various Routes,  Recent Advances in Drug Delivery Technology, Drug Targeting, Nanotechnology in Drug Delivery Systems and its Application, Major Challenges in Drug Delivery System,   Physiological Considerations, Vaccine Drug Delivery Systems, Drug Discovery and Development, Medical Devices for Drug Delivery, Smart Drug Delivery Systems, Delivery Methods for Peptides and Biologics, Global Drug Policy in Drug Delivery Technology.

Track-1:  Pre-formulation Considerations

Pharmaceutics is the study of relationships between preformulation, drug formulation, delivery, disposition and clinical response. The inherent instability nature of a new drug will alter its desired form into undesired form when presented in a suitable dosage form with the excipient/s upon storage.  In early days this process was confined only for assessing few characteristics, but   today   this   process   is   being   considered   as   a   formulation strategy   and   the   tremendous   technological advancement  has  been  achieved  in  this  field  which  enables  us  to  save   time  and  money  through  planned management system and hence impacts Pharmaceutica 2016 to be a formulation conference. Use of glorious statistical software even based on artificial neural networking are made the task of preformulation and optimization process easier. Role of preformulation studies techniques like freeze drying aspects projects the event Pharmaceutica 2016 to pose as a freeze drying meeting in drug discovery, drug development plays major role in pharmaceutical formulation development and the studies will help in different dosage forms design. With the increasing number of novel and specialized compounds being developed, a "one size fits all" approach to drug formulation and delivery is no longer optimal, necessitating the consideration of formulations unique to each drug. NDDS conference will discuss on Early Approaches, Present Scenario and Future Prospects of Preformulation events. There are more than 1400 sustained or controlled release drugs have been approved all over the world. Pharmaceutical conferences discusses the state-of-the-art technology being applied and advances in formulation studies. 

Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of overall international pharmaceutical market. The utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively.

The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of the market share. It is presently valued at $49 billion and is expected to reach over $90 billion by 2016, at a CAGR of 11%. The growth in the oral drug delivery market shall be driven primarily by newer technologies enabling controlled release formulations of oral drugs and oral formulations of injectable only drugs.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4^th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; Asia Pacific Drug Formulation & Bioavailability Congress June 06-08, 2016 Beijing, China; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; 2^nd Annual Formulation & Drug Delivery Congress 2016 May 18-19, 2016 London, UK; Drug Development, Pharmacokinetics and Imaging January 18-22, 2016 Oxford, UK; Novel Immunotherapeutics Summit January 25-26, 2016 San Diego, US; ICDDT-7^th International Conference on Drug Discovery and Therapy February 15-18, 2016 Dubai, UAE; Africa Pharmaceutical Summit February 24-25, 2016 Nairobi, Kenya; 11^th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 5^th RSC / SCI symposium on Ion Channels as Therapeutic Targets March 14-15, 2016 Cambridge, UK.

Track-2: Formulation Aspects for Various Drug Routes

There are various anatomical routes which thought them medical drugs can be administered into the human body. The selection of the route depends on three factors which are: the effect desired the type of the disease and finally the type of the product. The most common routes of drug administration include the following:

Oral route, this is the oldest route which has been used for conventional and novel drug delivery administration. Parenteral route, these routes include intramuscular, intravenous, intra-arterial and subcutaneous route. Transdermal route, this route the medical treatment will apply on the body surfaces such as the skin and / or mucous membrane. Inhalation route, In this type of medical treatment application route, the medical treatment will directly reach the lungs, by this way this route considers the route of choice to avoid systemic effect i.e., increase the bioavailability of the drug in the system. Pharmaceutical conferences offers presentations by researchers from a number of disciplines, from the life sciences to engineering, who will address a range of topics including peptide and protein delivery, gene delivery, cell delivery, vaccines, transdermals, pulmonary delivery, new materials, and other subjects, from varied disciplines while focusing on the central theme of drug delivery.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4^th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; Asia Pacific Drug Formulation & Bioavailability Congress June 06-08, 2016 Beijing, China; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; 2^nd Annual Formulation & Drug Delivery Congress 2016 May 18-19, 2016 London, UK; Drug Development, Pharmacokinetics and Imaging January 18-22, 2016 Oxford, UK; Novel Immunotherapeutics Summit January 25-26, 2016 San Diego, US; ICDDT-7^th International Conference on Drug Discovery and Therapy February 15-18, 2016 Dubai, UAE; Africa Pharmaceutical Summit February 24-25, 2016 Nairobi, Kenya; 11^th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 5^th RSC / SCI symposium on Ion Channels as Therapeutic Targets March 14-15, 2016 Cambridge, UK.

Track-3: Recent Advances in Drug Delivery Technology

Drug delivered can have significant effect on its efficacy. Some drugs have an optimum concentration range with in which maximum benefit is derived and concentrations above (or) below the range can be toxic or produce no therapeutic effect. Various drug delivery and drug targeting systems are currently under development and being showcased in various targeted drug delivery systems conferences and Novel Drug Delivery system conferences across the globe.  The  main  goal  for  developing  such  delivery  systems is  to  minimize  drug degradation  and  loss,  to  prevent  harmful  side  effects  and  to  increase  bioavailability.  Targeting is the ability to direct the drug loaded system to the site of interest. New drug carriers systems are one can name soluble polymers,   micro particles   made   of   insoluble   (or)   biodegradable   natural   and   synthetic   polymers, microcapsules, cells, cell ghosts, lipoproteins, liposomes and micelles. Pharmaceutica 2016 evolves to be a drug disintegration conference, emulsion conference, capsule conference, and solubility conference. Pharmaceutical conferences will cover industry case studies, regulatory updates, latest therapies and technology innovations and much more. 

Key players in the market include Amgen, Inc., AstraZeneca plc, Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, PolyPeptide Group, and Peptisyntha Inc. at the pharmaceutical companies’ conference

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4^th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; Novel Immunotherapeutics Summit January 25-26, 2016 San Diego, US; Antibodies as Drugs March 06-10, 2016 Whistler, Canada; Drug Delivery Partnerships 2016 (DDP 2016) January 20-22, 2016 Florida, USA; Pharmapack Europe February 10-11, 2016, Paris Expo Porte De Versailles; 7^th Annual Global Drug Delivery & Formulation Summit May 23-25, 2016 Berlin, Germany; 6^th American Drug Delivery & Formulation Summit June 12-14, 2016 Hilton San Diego, US; Respiratory Drug Delivery (RDD 2016) April 17-21, 2016 Phoenix, Arizona.

Track-4: Drug Targeting

Drug Targeting to specific organs and tissues has become one of the critical endeavours of the century since the use of free drugs in conventional dosage forms generally involves difficulties in achieving the target site at the appropriate dose after or during a proper time period. Consequently, the search for new drug delivery approaches and new modes of action represent one of the frontier research areas. Major discussion on this session includes Applications of drug targeting, Targeting approaches, Issues in drug targeting, Brain targeted drug delivery system and Antibody targeted-drug conjugates. Pharmaceutica 2016 is considered to be a BBB drug delivery meeting and the conference offers more discussions on Challenges and advancements in blood brain barrier targeted drug delivery. Pharmaceutical conferences will showcase innovative manufacturing approaches and how they are being applied, particularly to address healthcare needs in developing countries and other international markets.

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4^th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany;     Drug Discovery & Therapy World Congress 2016 May 11th - 14th, 2016, Boston, MA, USA; microRNA as Biomarkers and Diagnostics April 4-5, 2016 Cambridge, UK; Molecular Diagnostics Europe April 4-6, 2016 Lisboa, Portugal; The Biomarker Conference December 10-11, 2015 Orlando, USA; G Protein-Coupled Receptors: Structure, Signaling and Drug Discovery February 21-25, 2016 Keystone, US.

Track-5: Nanotechnology in Drug Delivery Systems

Nanotechnology has finally and firmly entered the realm of drug delivery. Performances of intelligent drug delivery systems are continuously improved with the purpose to maximize therapeutic activity and to minimize undesirable side-effects. There are multiple Applications of Nanotechnology in Drug Delivery systems are based on micelles, polymeric nanoparticles, and dendrimers. Polymeric carbon nanotubes and many others demonstrate a broad variety of useful properties. The following dosage forms using Nanotechnology in Drug Delivery Systems are Liposomes as potential drug carrier systems for drug delivery and project Pharmaceutica 2016 to pose as a liposome event during the conference , Techniques for the preparation of solid lipid nano and microparticles, Nanoemulsions applications, Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases, Dermal, Transdermal Drug Delivery, Insulin Drug Delivery and Organic Nanotubes as a Promising Vehicles for Drug Delivery. NDDS conference will discuss on the Current Status and Future Scope for Nanomaterials in Drug Delivery and reflect on pharmaceutical technology conference. Interestingly pharmaceutical sciences are also using nanoparticles to reduce toxicity and side effects of drugs. The potential to cross the Blood Brain Barrier (BBB) has open new ways for drug delivery into the brain. In addition, the nanosize also allows for access into the cell and various cellular compartments including the nucleus. Nanoparticles are also considered to have the potential as novel intravascular or cellular probes for both diagnostic and therapeutic purposes (drug/gene delivery), which is expected to generate innovations and play a critical role in medicine.

Key players in the market include Amgen, Inc., AstraZeneca plc, Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, PolyPeptide Group, Peptisyntha Inc. and Lonza Inc.   

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

Relevant Conferences:

6^th Global Experts Meeting & Expo on Nanomaterials and Nanotechnology April 21-23, 2016 Dubai, UAE; 7^th World Nano Conference May 19-21, 2016 Osaka, Japan; 11^th International Conference and Expo on Nanoscience and Molecular Nanotechnology September 26-28, 2016 London, UK; 13^th International Conference on Nanotek and Expo December 05-07, 2016 Seattle, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering April 1-2, 2016 Prague, Czech Republic; 10^th World Biomaterials Congress May 17-22, 2016 Montreal, QC Canada; IEEE-NANO 2016 (16^th International Conference on Nanotechnology) August 22-25, 2016 Sendai, Japan; IEEE-NANOMED 2016 (10^th IEEE International Conference on Nano/Molecular Medicine and Engineering) November 2016; IEEE NMDC 2016 (11^th Nanotechnology Materials and Devices Conference) October 9-12, 2016 Toulouse, France.

Track-6: Application of Nanotechnology in Drug Delivery

Nanotechnology has finally and firmly entered the realm of drug delivery. Performances of intelligent drug delivery systems are continuously improved with the purpose to maximize therapeutic activity and to minimize undesirable side-effects. The primary goals for research of nano-bio-technologies in drug delivery include:

• More specific drug targeting and delivery,
• Reduction in toxicity while maintaining therapeutic effects,
• Greater safety and biocompatibility, and
• Faster development of new safe medicines

Pharmaceutical conferences offers presentations by researchers from a number of disciplines, from the life sciences to engineering, who will address a range of topics including peptide and protein delivery, gene delivery, cell delivery, vaccines, transdermals, pulmonary delivery, new materials, and other subjects, from varied disciplines while focusing on the central theme of drug delivery.

Key players in the market include Amgen, Inc., AstraZeneca plc, Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, PolyPeptide Group, Peptisyntha Inc. and Lonza Inc.   

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4^th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering April 1-2, 2016 Prague, Czech Republic; 10^th World Biomaterials Congress May 17-22, 2016 Montreal, QC Canada; IEEE-NANO 2016 (16^th International Conference on Nanotechnology) August 22-25, 2016 Sendai, Japan; IEEE-NANOMED 2016 (10^th IEEE International Conference on Nano/Molecular Medicine and Engineering) November 2016; IEEE NMDC 2016 (11^th Nanotechnology Materials and Devices Conference) October 9-12, 2016 Toulouse, France.

Track-7: Major Challenges in Drug Delivery System

Major Challenges in Drug Delivery Systems are delivery of poorly soluble drugs and bioavailability hurdles for poorly soluble clinical candidates. There are several Novel approaches in the delivery, Overcoming bioavailability hurdles and Rationale formulation design of poorly soluble drugs. Other Major Challenges in Drug Delivery are protein drug delivery, paediatric and geriatric drug delivery.  Self-emulsifying drug delivery systems (SEDDS) possess unparalleled potential in improving oral bioavailability of poorly water-soluble drugs. Taking dosage form into consideration makes the event Pharmaceutica 2016 a dosage form meeting. Pharmaceutical conferences will cover industry case studies, regulatory updates, latest therapies and technology innovations and much more.

There is an increasing demand for effective and, ideally, non-invasive drug-delivery methods. This is especially the case for the biopharmaceutical sector, which has experienced an overwhelming growth due to advances in biotechnology. In 2009, over $12 billion were invested in biologics / biotechnology research and development (R&D), representing a 26% share in the total R&D expenditure. A recent report by the Pharmaceutical Research and Manufacturers of America (PhRMA) states that in 2015 there were 901 biological in development, targeting more than 100 diseases.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4^th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; Novel Immunotherapeutics Summit January 25-26, 2016 San Diego, US; Antibodies as Drugs March 06-10, 2016 Whistler, Canada; Drug Delivery Partnerships 2016 (DDP 2016) January 20-22, 2016 Florida, USA; Pharmapack Europe February 10-11, 2016, Paris Expo Porte De Versailles; 7^th Annual Global Drug Delivery & Formulation Summit May 23-25, 2016 Berlin, Germany; 6^th American Drug Delivery & Formulation Summit June 12-14, 2016 Hilton San Diego, US; Respiratory Drug Delivery (RDD 2016) April 17-21, 2016 Phoenix, Arizona.

Track-8: Physiological Considerations

Drug Delivery system method by which a drug is delivered can have a significant effect on its efficacy. NDDS Conference includes topics like Anatomical, biochemical and physiological considerations in design and development of novel drug delivery systems, Pharmacokinetics in drug design, Pharmacokinetic behaviour of conventional and novel dosage forms, In-silico drug discovery and development, Computational methods in ADME and toxicity studies, Pharmacokinetic parameters for drug input and drug disposition. Pharmaceutical conferences explores recent advances in liposome technology and interaction of liposomes with the body

The global revenue for advanced drug delivery systems is estimated to be $151.3 billion in 2013. In 2018, revenues are estimated to reach nearly $173.8 billion, demonstrating a compound annual growth rate (CAGR) of 2.8%.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4^th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; Non-Invasive Delivery of Macromolecules Conference 2016 February 18-21, 2016 Carlsbad, CA, USA; 6^th Annual Drug Delivery & Formulation Americas Summit April 14-15, 2016 California, USA; 2^nd Drug Delivery Strategy: Advanced Mechanisms & Product Design May 18-19, 2016 Philadelphia, USA; 29^th Annual Pharmacokinetics for Pharmaceutical Scientists Course 29 February - 04 March 2016 San Francisco, CA; Drug Delivery Partnerships 2016 (DDP 2016) January 20-22, 2016 Florida, USA.

Track-9: Vaccine Drug Delivery Systems

In Vaccine Drug Delivery there are multidisciplinary scientific field that is currently undergoing rapid development. An important component of cancer vaccines is the development of novel vaccine delivery strategies; this session includes Importance of immunostimulatory adjuvant, Advances in Vaccine Drug Delivery, Laser technology for Vaccine Delivery, Challenges and opportunities For Vaccine Delivery, Jet injectors and micro needles, Development of colloidal vaccine drug delivery systems. Pharmaceutical conferences will showcase innovative manufacturing approaches and how they are being applied, particularly to address healthcare needs in developing countries and other international markets.

Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017 at a compound annual growth rate (CAGR) of 5.3%.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; International Hepatitis Vaccines  Conference June 16-18, 2016 Rome, Italy; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; 10^th Euro Vaccines & Vaccination Summit June 16-18, 2016 Rome, Italy; Antibodies as Drugs March 06-10, 2016 Whistler, Canada; HIV Vaccines March 20-24, 2016 Olympic Valley, USA; ECI — Vaccine Technology VI June 12-17, 2016 Calabria, Italy; Vaccine Technology VI June 12-17, 2016 Albufeira, Portugal; 19^th Annual Conference on Vaccine Research April 18-21 Baltimore, USA.

Track-10: Drug Discovery and Development

Biotherapeutics conference session is beginning to change for small, medium, and large scale pharmaceutical & biotechnology companies which can manifest from development to manufacturing. Addressing these instabilities is a great challenge, because of the complexity of the bio therapeutics themselves. This session includes Design and development of biotherapeutics, Tools for biotherapeutics generation, Dry biopharmaceuticals and applications, Biopharmaceutical drugs from natural sources, Formulation techniques for biopharmaceuticals, RNAi, Gene therapeutics, Nucleic acid and Cell therapy. Pharmaceutica 2016 majorly projects to be a biotherapeutics conference with vast scope of future advances and inventions.

Key players profiled in this report include Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Lonza Group, Patheon, Inc., Piramal Healthcare, Accellent, Symmetry Medical, Inc. and Greatbatch, Inc.

The global market for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging was $219.9 billion in 2012. This market is estimated to reach $242.2 billion in 2013 and $374.8 billion by 2018, a five-year compound annual growth rate (CAGR) of 9.1%.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 2^nd International Conference and Expo on Drug Discovery & Designing October 24-26 Istanbul, Turkey; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; Drug Development, Pharmacokinetics and Imaging January 18-22, 2016 Oxford, UK; Novel Immunotherapeutics Summit January 25-26, 2016 San Diego, US; ICDDT-7^th International Conference on Drug Discovery and Therapy February 15-18, 2016 Dubai, UAE; Drug Discovery & Therapy World Congress 2016 May 11-14, 2016, Boston, MA, USA; Drug Delivery Partnerships 2016 (DDP 2016) January 20-22, 2016 Florida, USA.

Track-11: Medical Devices for Drug Delivery

In this session we will focus on medical devices designed for drug delivery through the pulmonary and nasal routes. These routes are of interest for local delivery, as in asthma, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that account for specific anatomical and physiological features of the intranasal and pulmonary routes will be featured.  Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treatments. Many in the industry have long felt overly burdened by what they consider to be an unnecessarily complex approval process. Critics claim it impedes innovation and delays the availability of better health care. In order to help innovators bring health care to the public Pharmaceutica 2016 hosts drug delivery conferences throughout the year which happened to be the event pharma conference dubai in 2015.

To change that perception, the FDA last year announced $40 million to a new Medical Device Innovation Consortium (MDIC) charged with simplifying the process of designing and testing new technologies. With input from industry, government, and other non-profit organizations, public-private MDIC will prioritize the regulatory science needs of the medical device community and fund projects to streamline the process.

The drug-device combination market is not fragmented and the key players in this market are Medtronic, Boston Scientific Corp., Edwards Life sciences Corp., Stryker Corp., QLT Inc. etc. The maximum number of new product developments is expected to take place in the bone graft substitutes, advanced wound care products and antimicrobial catheter markets. Our patent analysis indicates that E.U. has filed for the maximum number of patents followed by the U.S.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 2^nd World Congress and Expo on Medical Devices December 01-03, 2016 Baltimore, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; Design of Medical Devices Conference 2016 April 11-14, 2016 Minneapolis, USA; The 10x Medical Device Conference May 2016, San Diego, USA; BIOMEDevice April 13-14, 2016 Boston, USA; ADVAMED 2016, Medical Devices, Diagnostic Products and Health Information Systems Conference October 17-19, 2016 Minneapolis, USA; MEDTEC Europe & SUDTEC April 12-14, 2016 Stuttgart, Germany.

Track-12: Smart Drug Delivery Systems

To maximize knowledge of the current researcher on developing drug delivery via smart polymers, Smart Drug Delivery i.e. NDDS conference themed quality topics on Polymer Nanoparticles for smart drug delivery, pH and Environmental sensitive, BioMEMS smart drug delivery system, Delivery through Versatile polymers in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry and hence a pharmaceutics conference. Pharmaceutical conferences will cover industry case studies, regulatory updates, latest therapies and technology innovations and much more.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex.

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; 2^nd World Congress and Expo on Medical Devices December 01-03, 2016 Baltimore, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; Non-Invasive Delivery of Macromolecules Conference 2016 February 18-21, 2016 Carlsbad, CA, USA; 6^th Annual Drug Delivery & Formulation Americas Summit April 14-15, 2016 California, USA; 2^nd Drug Delivery Strategy: Advanced Mechanisms & Product Design May 18-19, 2016 Philadelphia, USA; Pharmapack Europe February 11-12, 2016 Paris, France; Drug Delivery Partnerships 2016 (DDP 2016) January 20-22, 2016 Florida, USA.

Track-13: Delivery Methods for Peptides and Biologics

Major drugs driving growth of the overall peptide therapeutics market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex. As these drugs lose their patent exclusivity in the near future, the market for generic peptide drugs would flourish. However, difficulty in synthesis of complex peptides has restricted growth of the generic peptide drugs market. Pharmaceutical conferences offers recent advancements in biologics and small molecule drugs formulation research, advanced solid and liquid formulations strategies and novel drug delivery technologies

Key players in the market include Amgen, Inc., AstraZeneca plc, Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, PolyPeptide Group. 

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; 2^nd World Congress and Expo on Medical Devices December 01-03, 2016 Baltimore, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; Peptides and Peptidomimetics: Inspired by Nature and Applied by Scientists February 20-21, 2016 Ventura, USA; 3rd Annual Peptides Congress 2016 April 18-19, 2016 London, UK; BIT's 9^th Annual World Protein & Peptide Conference April 25-18, 2016 Dalian, China; Non-Invasive Delivery of Macromolecules Conference 2016 February 18-21, 2016 Carlsbad, San Diego, USA; 9^th Annual Proteins & Antibodies Congress 2016 April 18-19, 2016 London, UK.

Track-14: Global Drug Policy in Drug Delivery Technology

The global market for Business Development of Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. The U.S. constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6% for 2013, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists.

Consistent quality and competitive costs of product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, quality control, and business development Business opportunities in drug delivery. Pharmaceutical conferences offers unparalleled opportunities to establish new business relationships with companies from 40 countries through pre-scheduled one-on-one meetings with decision makers.

Relevant Conferences: 

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; 2^nd World Congress and Expo on Medical Devices December 01-03, 2016 Baltimore, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016 Bangkok, Thailand; 2016 Students for Sensible Drug Policy Conference April 15-16, 2016 Washington, USA; UN General Assembly Special Session on Drugs (UNGASS) 2016 April 19-21, 2016 New York, USA; 10^th Annual Conference of the International Society for the Study of Drug Policy May 16-18, 2016 Sydney, Australia; 3^rd International Conference on Law enforcement and Public Health October 2-5, 2016 Amsterdam, Netherlands; 11^th National Harm Reduction Conference November 3-6, 2016 San Diego, USA.